NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 2, 2013
Insider Transaction Report
Form 4
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Award
Option (right to buy)
2013-09-26−62,000→ 319,823 totalExercise: $1.71From: 2014-09-26Exp: 2023-09-26→ Common Stock (62,000 underlying)
Footnotes (2)
- [F1]Options granted pursuant to 2007 Omnibus Incentive Plan
- [F2]25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter